Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
This paragraph explains how to identify dividend ETFs with the lowest management fees and compare options side by side.
27,460 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
New data from Goldman Sachs shows AI-driven job losses remain concentrated in early-career roles, with Gen Z bearing ...
Market rallies can mask drift in your asset mix. Learn why right now is a great moment to rebalance and how to do it ...
Former Prime Minister Justin Trudeau has purchased a Montreal mansion for $3.1 million, a move that has investors wat...
As Kevin Warsh opens his first Federal Reserve meeting, AMD sits near all-time highs. Analysts and traders weighing e...
Semiconductors led by the SMH and SOXX pulled back sharply, triggering fresh talk of a buyable dip. Famous tech inves...
Oil volatility faded and mortgage demand held firm in the first half of 2026, underscoring resilience in the housing ...
C.H. Robinson is pursuing a Lean AI powered transformation led by CEO Dave Bozeman, aiming to turn the freight broker...
Memecore tumbles once more while Bitcoin hovers near the 63,000 level, triggering a fresh wave of trading activity an...
Intuitive Surgical stock has faced a challenging 2026, dipping from highs and patchy returns as investors weigh multi...
Bitcoin options totaling roughly $2B are set to expire Friday, with markets flat and volatility subdued. Traders are ...
Atlassian Corp. PLC posted stronger-than-expected Q1 results, but its stock has still tumbled. With 25 analysts stick...